– NASDAQ:JUPW
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 4 hours
stock price monthly change
+19.68%
month
stock price quarterly change
+313.04%
quarter
stock price yearly change
+53.53%
year
key metrics
Market Cap | 49.33M |
Enterprise value | 7.12M |
P/E | -0.41 |
EV/Sales | 1.04 |
EV/EBITDA | -0.32 |
Price/Sales | 1.48 |
Price/Book | 1.18 |
PEG ratio | N/A |
EPS | N/A |
Revenue | 5.30M |
EBITDA | -12.09M |
Income | N/A |
Revenue Q/Q | -42.03% |
Revenue Y/Y | -22.43% |
Profit margin | -345.76% |
Oper. margin | -163.54% |
Gross margin | 19.93% |
EBIT margin | -163.54% |
EBITDA margin | -228.19% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freestock price history
stock forecast
financial statements
| Dec 2022 | 905.60K | -9.98M | -1102.39% |
|---|---|---|---|
| Mar 2023 | 1.12M | -1.36M | -121.85% |
| Jun 2023 | 2.36M | -359.59K | -15.2% |
| Sep 2023 | 910.00K | 0 |
| Dec 2022 | 8690763 | 5.02M | 57.82% |
|---|---|---|---|
| Mar 2023 | 10906613 | 5.09M | 46.75% |
| Jun 2023 | 11079508 | 5.41M | 48.84% |
| Sep 2023 | 11331430 | 4.62M | 40.79% |
| Dec 2022 | -1.64M | 20.40K | -9.07K |
|---|---|---|---|
| Mar 2023 | -1.46M | -26.07K | 3.30M |
| Jun 2023 | -627.76K | -524.53K | 187.67K |
| Sep 2023 | -7.73M | 0 | 0 |
alternative data
| Aug 2023 | 10 |
|---|---|
| Sep 2023 | 10 |
| Oct 2023 | 10 |
| Nov 2023 | 10 |
| Dec 2023 | 10 |
| Jan 2024 | 10 |
| Feb 2024 | 10 |
| Mar 2024 | 10 |
| Apr 2024 | 10 |
| May 2024 | 10 |
| Jun 2024 | 10 |
| Jul 2024 | 10 |
other data
10.37%
-4.00%
of JUPW is owned by hedge funds
2.29M
-802.07K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Aug 2023 | 1685166 | 0 |
| Dec 2023 | 8000 | 0 |
| Patent |
|---|
Application Filling date: 21 Jun 2021 Issue date: 23 Dec 2021 |
Application Filling date: 7 Aug 2020 Issue date: 11 Feb 2021 |
-
When is 's next earnings date?
Unfortunately, 's (JUPW) next earnings date is currently unknown.
-
Does pay dividends?
No, does not pay dividends.
-
How much money does make?
has a market capitalization of 49.33M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 115.44% to 6.2M US dollars.
-
What is 's stock symbol?
null is traded on the NASDAQ under the ticker symbol "JUPW".
-
What is 's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of ?
Shares of can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are 's key executives?
's management team includes the following people:
- Mr. Brian Scott John Chief Investment Officer, Chief Executive Officer & Executive Director(age: 56, pay: $223,580)
- Mr. Richard A. Miller Chief Compliance Officer, Sec. & Director(age: 57, pay: $124,000)
- Dr. Glynn Wilson Ph.D. Chief Science Officer & Chairman(age: 78, pay: $4,000)
-
How many employees does have?
As Jul 2024, employs 10 workers.
-
When went public?
null is publicly traded company for more then 4 years since IPO on 30 Oct 2020.
-
What is 's official website?
The official website for is jupiterwellness.com.
-
Where are 's headquarters?
is headquartered at 1061 East Indiantown Road, Jupiter, FL.
-
How can i contact ?
's mailing address is 1061 East Indiantown Road, Jupiter, FL and company can be reached via phone at +56 12447100.
company profile:
Exchange:
NASDAQ
Full time employees:
10
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the CaniSun brand; CBD-infused skin care lotion under the CaniSkin brand; and products for the dermatological treatments of pain and inflammation under the CaniDermRX brand. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.
1061 East Indiantown Road
Jupiter, FL 33477
Jupiter, FL 33477
CIK: 0001760903
ISIN: US48208F1057
CUSIP: 48208F105
